Publication | Journal of Industrial Microbiology & Biotechnology 2018

Biotechnology software in the digital age: are you winning?


Biotechnology software in the digital age: are you winning?

Cornelia Scheitz, Larry Peck, Eli Groban

Journal of Industrial Microbiology & Biotechnology 2018

There is a digital revolution taking place and biotechnology companies are slow to adapt. Many pharmaceutical, biotechnology, and industrial bio-production companies believe that software must be developed and maintained in-house and that data are more secure on internal servers than on the cloud. In fact, most companies in this space continue to employ large IT and software teams and acquire computational infrastructure in the form of in-house servers. This is due to a fear of the cloud not sufficiently protecting in-house resources and the belief that their software is valuable IP. Over the next decade, the ability to quickly adapt to changing market conditions, with agile software teams, will quickly become a compelling competitive advantage. Biotechnology companies that do not adopt the new regime may lose on key business metrics such as return on invested capital, revenue, profitability, and eventually market share.

Download publication

Related Resources



Considering Multiscale Scenes to Elucidate Problems Encumbering 3D Intellection and Navigation

Virtual 3D environments have become pervasive tools in a number of…



Toward Better Surface Tracking for Fluid Simulation



Ellis Auditorium: The Design of a Scalable, Fun and Beautiful, Socializing Webcast Experience

Today’s commercial webcast applications are largely designed as…



Simulation and the Future of Design Tools for Ecological Research

As buildings mediate between a complex external system (weather) and a…

Get in touch

Something pique your interest? Get in touch if you’d like to learn more about Autodesk Research, our projects, people, and potential collaboration opportunities.

Contact us